Rare Diseases Activities
Advancements in Treating and Managing Long-Chain Fatty Acid Oxidation Disorders, featuring a Patient Perspective
0290-0000-21-217-H01-P
This activity will focus on current treatment options and provide specialty and managed care pharmacists with a better understanding of the management of these rare disorders and their impact on the lives of patients and caregivers through a patient interview.
1.50
The Evolving Treatment Landscape for Neuromyelitis Optica Spectrum Disorder: Updates for Specialty and Infusion Pharmacists
0290-0000-21-218-H01-P
Examine the patient population afflicted with neuromyelitis optica spectrum disorder (NMOSD), including factors related to epidemiology, etiology, pathophysiology, clinical presentation, and diagnostic challenges
1.50
Closing the Gap in Hemophilia Care: Therapeutic Advances in Hemophilia A and B
0290-0000-21-208-H01-P
This activity will detail the pathophysiology of both hemophilia A and B, as well as historic and emerging treatments used in clinical practice for both variants of this condition.
1.50
Effective Utilization of Combination Therapies in Pulmonary Arterial Hypertension : Working Towards Low Risk Status for Patients, featuring Evidence-Based Case Reviews
0290-0000-21-212-H01-P
Distinguish between different treatment approaches to improve clinical outcomes in PAH including the use of dual and triple regimens
1.50